Physiological mechanisms underlying alterations in diet preference
饮食偏好改变的生理机制
基本信息
- 批准号:10397643
- 负责人:
- 金额:$ 14.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAreaBody Weight decreasedBrainBrain regionCephalicCholecystokininCholecystokinin ReceptorChronicCranial NervesCuesDataDietDoseEatingFastingFeedbackFeeding behaviorsFemaleFoodFood deprivation (experimental)GLP-I receptorGastrointestinal tract structureHealthHomeostasisHourHumanHypertensionImmunohistochemistryIntakeMeasuresMetabolicMotivationNeural PathwaysNeuraxisNon-Insulin-Dependent Diabetes MellitusNucleus solitariusObesityOral cavityPathway interactionsPatternPeptide Signal SequencesPeptidesPhysiologicalPlayPopulationPreparationProcessProsencephalonRattusReceptor ActivationReflex actionReportingRewardsRisk FactorsRoleSatiationScheduleSensorySex DifferencesSignal TransductionStimulusStructureTaste BudsTaste PerceptionTestingantagonistcohortdesigndietingexperimental studyfeedingfeeding scheduleglucagon-like peptide 1hedonicimprovedinterestmalemotivational processesneuromechanismpreferencereceptorreduced food intakerelating to nervous systemresponsetaste stimuli
项目摘要
ABSTRACT
Obesity is a key risk factor for chronic health complications including hypertension and Type II
diabetes. Alternate day fasting (ADF) which involve cycles of feeding and fasting have been
effective for weight loss and improving metabolic measures in humans and rats. We have
recently reported that rats presented both standard chow and a high energy (HE) diet show
almost exclusive intake of the HE diet. Yet, rats on an ADF paradigm show decreased HE diet
preference driven by increased chow intake. Meal pattern analyses that provide parameters such
as meal size and number, reveal differences in male and female rats on an ADF schedule. Meal
pattern parameters are driven by physiological signals that drive intake (e.g. orosensory
stimulation and meal initiation) and terminate intake (e.g. satiety). Here, male and female ADF
and control rats will be compared to investigate the role of 1) taste signaling and 2) gut peptide
influences, in ADF-induced shifts in diet preference. Using cFos immunohistochemistry,
activation of brain areas in central gustatory pathways associated with taste identification and
reward will be compared between the groups (Experiment 1). These experiments are designed to
test the hypothesis that rats on ADF and control feeding schedules show similar activation of
brain regions involved in taste identification but that ADF rats show decreased neural activation
of taste pathways involved in reward. Another cohort of male and female ADF and control rats
will be used (Experiment 2) to investigate the role of gut peptides shown to be involved in satiety
(CCK) and both satiety and reward (GLP-1). Groups will be administered agonists and
antagonists of CCK and GLP-1 receptors to test the hypothesis that shifts in diet preference
induced by an ADF schedule, reduces gut signals related to reward but not satiety. The
experiments are designed to assess how meal pattern parameters are altered with feeding
schedule and gut peptide administration. The findings from the proposed experiments will
provide information about how neural mechanisms related to taste and gut signaling drive
changes in diet preference.
摘要
肥胖是包括高血压和II型糖尿病在内的慢性健康并发症的关键危险因素
糖尿病隔日禁食(ADF)涉及喂养和禁食的周期,
对减轻体重和改善人类和大鼠的代谢措施有效。我们有
最近报道,大鼠同时提供标准食物和高能量(HE)饮食,
几乎完全摄入HE饮食。然而,ADF范式的大鼠显示出减少的HE饮食,
食物摄入量增加导致的偏好。膳食模式分析提供参数,
作为膳食大小和数量,揭示了雄性和雌性大鼠在ADF时间表上的差异。餐
模式参数由生理信号驱动
刺激和进餐开始)和终止摄入(例如饱腹感)。在这里,男性和女性的ADF
和对照组大鼠进行比较,以研究1)味觉信号传导和2)肠肽的作用
影响,在ADF诱导的饮食偏好的变化。使用cFos免疫组织化学,
激活与味觉识别相关的中枢味觉通路中的脑区,
奖励将在各组之间进行比较(实验1)。这些实验旨在
测试ADF和对照喂养时间表的大鼠显示类似的激活的假设,
大脑区域参与味觉识别,但ADF大鼠显示神经激活减少
味觉通路参与奖赏的过程另一组雄性和雌性ADF大鼠和对照大鼠
将被用于(实验2)研究显示参与饱腹感的肠肽的作用
(CCK)以及饱腹感和奖赏(GLP-1)。各组将给予激动剂,
CCK和GLP-1受体拮抗剂,以检验饮食偏好改变的假设
由ADF时间表诱导,减少了与奖励有关的肠道信号,但不是饱腹感。的
设计实验来评估膳食模式参数如何随着进食而改变
时间表和肠肽给药。从拟议的实验结果将
提供有关味觉和肠道信号驱动的神经机制的信息
饮食偏好的变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yada Treesukosol其他文献
Yada Treesukosol的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yada Treesukosol', 18)}}的其他基金
Physiological mechanisms underlying alterations in diet preference
饮食偏好改变的生理机制
- 批准号:
10624229 - 财政年份:2021
- 资助金额:
$ 14.74万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 14.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 14.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 14.74万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 14.74万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 14.74万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 14.74万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 14.74万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 14.74万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 14.74万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 14.74万 - 项目类别: